Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-21 · accession 0001415889-22-009828 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-22 | 2022-09-21 | FENC | Andrade Robert | CFO | D - Sale to Iss | $8.54 | -19.1K | 171.7K | -10% | -$162.7K | |
| 2022-09-22 | 2022-09-21 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +37.5K | 190.8K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2022-09-21 | D | D | 19,052 | $8.54 | 171,721 | D | — | — | (F2) On September 21, 2022, 19,052 shares were netted back to the company to pay the taxes on the common shares released from restriction. |
| 2 | Common | Common shares | 2022-09-21 | A | A | 37,500 | $0.00 | 190,773 | D | — | — | (F1) On September 21, 2022, 37,500 restricted share units were released from their restriction. |